Non-Toxic Dimeric Peptides Derived from the Bothropstoxin-I Are Potent SARS-CoV-2 and Papain-like Protease Inhibitors

The COVID-19 outbreak has rapidly spread on a global scale, affecting the economy and public health systems throughout the world. In recent years, peptide-based therapeutics have been widely studied and developed to treat infectious diseases, including viral infections. Herein, the antiviral effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Freire, Marjorie C. L. C., Noske, Gabriela D., Bitencourt, Natália V., Sanches, Paulo R. S., Santos-Filho, Norival A., Gawriljuk, Victor O., de Souza, Eduardo P., Nogueira, Victor H. R., de Godoy, Mariana O., Nakamura, Aline M., Fernandes, Rafaela S., Godoy, Andre S., Juliano, Maria A., Peres, Bianca M., Barbosa, Cecília G., Moraes, Carolina B., Freitas-Junior, Lucio H. G., Cilli, Eduardo M., Guido, Rafael V. C., Oliva, Glaucius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401042/
https://www.ncbi.nlm.nih.gov/pubmed/34443484
http://dx.doi.org/10.3390/molecules26164896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401042/
https://www.ncbi.nlm.nih.gov/pubmed/34443484
http://dx.doi.org/10.3390/molecules26164896

Ejemplares similares